Invitation update: HealthBIO, 15.-16.9.2021, Turku Finland

Due to the current Covid-19 situation in Finland, only a limited number of participants can attend the on site HealthBIO Seminar on 15th of September. At the moment, the seminar is fully booked but we have set up a waiting list for this event. Please read more below.

We have also decided to change the HealthBIO 2021 Partnering event on 16th  of September into a digital event, which means that more companies will be able to attend.

HealthBIO Seminar, 15th of September – on-site event, limited number of participants
This year’s program includes an overview of the newest trends, and successful companies will share their latest insights on the development of the life-science business environment. The program also introduces the most significant projects in the life-science field: CancerIO focusing on immune-oncology, and InFlames focusing on immunology. An update of the situation of the national Drug Development Centre will also be presented.

Speakers of the day:
Petra Furu, PerkinElmer Wallac
Antti Haapalinna, Orion Pharma
Hannu Juvonen, Drug Development Centre/ Ministry of Social Affairs and Health
Jeroen Pouwels, CancerIO Project
Timo Veromaa, InFlames Flagship
Tero Piispanen, Turku Science Park Ltd
Chair: Maarit Merla, Forendo Pharma Ltd, Chairman of FIB

Please note: The HealthBIO seminar on 15th of September is fully booked. If you would like to be added to a waiting list for this event, please reply to this email by 3rd of September. In case the seminar will later be changed virtual, all registered will get a link to the online event.

HealthBIO 2021 online Partnering Event on 16th of September

Are you interested in partnering opportunities or investing in the life science companies?  Registration to HealthBIO Partnering is now open! This event will be held digitally, and arrangements are coordinated by Enterprise Europe Network (EEN). Register to the Partnering event and create your profile by 12th of September here: HealthBIO 2021 Partnering

More information: merja.tieaho(at)